Is accelerated corneal collagen cross-linking for keratoconus the way forward? No.

Macgregor, C., Tsatos, M. and Hossain, Parwez (2014) Is accelerated corneal collagen cross-linking for keratoconus the way forward? No. Eye. (doi:10.1038/eye.2014.98). (PMID:24788014) (In Press)

Abstract

Collagen cross-linking (CXL) was introduced in the late nineties and was later adopted as a treatment option for keratoconus, pellucid marginal degeneration, and post-LASIK ectasia in 2003.1, 2, 3 CXL is the only treatment modality for these conditions that addresses the underlying stromal weakening and thus halts disease progression. Recently, accelerated CXL was proposed as an alternative technique, whereby corneal stiffening can be achieved with higher fluence and reduced overall exposure time.

This record has no associated files available for download.

Contributors

Author: Parwez Hossain

Download statistics